rdf:type |
|
lifeskim:mentions |
umls-concept:C0021102,
umls-concept:C0033572,
umls-concept:C0041967,
umls-concept:C0178602,
umls-concept:C0205355,
umls-concept:C0376358,
umls-concept:C0449820,
umls-concept:C0596790,
umls-concept:C1420871,
umls-concept:C1457887,
umls-concept:C1512888,
umls-concept:C1522518,
umls-concept:C1704229,
umls-concept:C1705117,
umls-concept:C1705604,
umls-concept:C2827405
|
pubmed:issue |
10
|
pubmed:dateCreated |
2008-11-18
|
pubmed:abstractText |
To find the factors which influence the acute increment of International Prostate Symptom Score (IPSS) after transperineal permanent interstitial implant (TPI) using (125)I seeds.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0179-7158
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
184
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
515-9
|
pubmed:meshHeading |
pubmed-meshheading:19016040-Aged,
pubmed-meshheading:19016040-Aged, 80 and over,
pubmed-meshheading:19016040-Antineoplastic Agents, Hormonal,
pubmed-meshheading:19016040-Brachytherapy,
pubmed-meshheading:19016040-Combined Modality Therapy,
pubmed-meshheading:19016040-Follow-Up Studies,
pubmed-meshheading:19016040-Humans,
pubmed-meshheading:19016040-Iodine Radioisotopes,
pubmed-meshheading:19016040-Male,
pubmed-meshheading:19016040-Middle Aged,
pubmed-meshheading:19016040-Neoadjuvant Therapy,
pubmed-meshheading:19016040-Neoplasm Staging,
pubmed-meshheading:19016040-Perineum,
pubmed-meshheading:19016040-Prostate-Specific Antigen,
pubmed-meshheading:19016040-Prostatic Neoplasms,
pubmed-meshheading:19016040-Radiation Dosage,
pubmed-meshheading:19016040-Radiometry,
pubmed-meshheading:19016040-Urethra
|
pubmed:year |
2008
|
pubmed:articleTitle |
Urethral dose and increment of international prostate symptom score (IPSS) in transperineal permanent interstitial implant (TPI) of prostate cancer.
|
pubmed:affiliation |
Department of Radiation Therapy and Oncology, International Medical Center of Japan, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|